A Phase 1 interventional study of Cannabis and Dronabinol in Pain, Abuse, Drug and Intoxication; Cannabinoids, sponsored by University of California, Los Angeles. Recruiting at 1 site in United States. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-07.
Sponsored by University of California, Los Angeles · Phase 1, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 12 studies testing cannabis sativa subsp. indica TOP in Pain — 2 open to participants now, 5 under way, none of them phase 3. cannabis sativa subsp. indica TOP · Pain.
Among the 12 studies testing cannabis sativa subsp. indica TOP in Pain, this one is the 2nd largest by planned enrollment, is one of 2 that started in 2025, is one of 7 in phase 1, and was the 10th registered.
10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.
Browse Pain studies →2 of the 12 studies testing cannabis sativa subsp. indica TOP in Pain are open now, in 2 countries. Recruiting first, the newest first:
Khon Kaen University · Sites in Thailand
Ages 25–60
By country, each count listing its studies:
No approval found in the FDA or EMA files read. How studies give it is on its page →
Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
12 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 8 · Phase 2 4
First in 2006; this study’s year is marked. 2 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 103 is above the median of 66 across 8,512 interventional studies indexed under Pain.
Median enrollment 31 across the 12 interventional studies. Of the 6 that completed or were terminated, 3 (50%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 12 has an industry lead sponsor. The 7 most frequent:
University of California, Los Angeles is the lead sponsor of 1,172 studies on the registry; 195 are open to participants now.
Of its 95 completed or terminated interventional studies of FDA-regulated products, 70 (74%) have results posted.
22 studies in Pain by University of California, Los Angeles: 5 open now, 7 under way, none of them phase 3. Of 12 finished, 6 (50%) have results posted.
Among the 22 studies in Pain by University of California, Los Angeles, this one is the 6th largest by planned enrollment of the 21 interventional ones that give a count, is one of 3 that started in 2025, is one of 6 in phase 1, and was the 19th registered.
University of California, Los Angeles’s Pain studies by the year they started, since 2004.
None of the studies under way reaches primary completion within a year.
Among the 12 studies testing cannabis sativa subsp. indica TOP in Pain, from their registry updates:
Among University of California, Los Angeles’s 22 in Pain:
This tab as a report to print or save as PDF → With an account.
This study will assess the age-dependent effects of smoked and oral THC on abuse liability, intoxication, analgesia and impairment as a function of age.
The overall objective of this placebo-controlled, outpatient study is to compare the dose-dependent effects of smoked and oral THC on analgesia and endpoints directly related to adverse consequences of use including abuse liability, intoxication, and impairment as a function of age and sex.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Clinically significant
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraception
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
DSM diagnostic criteria
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Smoked Cannabis (0 mg THC) Oral placebo (0 mg THC)
Drug: Smoked Placebo · Drug: Oral Placebo
Smoked Cannabis (10 mg THC) Oral placebo (0 mg THC)
Drug: Cannabis · Drug: Oral Placebo
Smoked Cannabis (20 mg THC) Oral placebo (0 mg THC)
Drug: Cannabis · Drug: Oral Placebo
Smoked Cannabis (0 mg THC) Oral THC (10 mg THC)
Drug: Dronabinol · Drug: Smoked Placebo
Smoked Cannabis (0 mg THC) Oral THC (20 mg THC)
Drug: Dronabinol · Drug: Smoked Placebo
smoked cannabis
Also known as: Smoked cannabis with THC
Oral delta-9-THC
Also known as: Delta-9-THC
Placebo Cannabis
Also known as: Placebo smoked cannabis (no THC)
Oral Placebo
Subject-rated drug effects
Average and peak subjective ratings of drug effects associated with abuse liability and intoxication as measured using visual analogue scales (VAS; 1-100mm).
Time frame: 6 hours
Analgesia as measured using the Cold Pressor Test
Peak and average pain threshold and tolerance assessed using the Cold Pressor Test
Time frame: 6 hours
Impairment
The primary outcome measure for performance will be the peak difference from baseline scores of the Global Impairment Score
Time frame: 6 hours
Pharmacokinetics of THC and metabolites
Plasma levels of THC, 11-OH-THC, and THCCOOH
Time frame: 6 hours
Plan to share: No
No publications or documents are linked to this record.
Started Apr 2025 (actual). Primary completion is estimated for Oct 2028, 41 months after the start.
Of 118 non-industry phase 1 interventional studies under Pain, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 45. This study's planned 41 months is above that.
Counting every sponsor, half of 222 studies reached it within 9 months; a quarter within 3 and three quarters within 29.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Cannabis sativa subsp. indica TOP · Dronabinol
University of California, Los Angeles →